DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20171924

Study of clinical significance and histopathological correlation of serum β- hCG level

Faruq Ibrahimbhai Mulla, Kailash Sukhram Inaniya

Abstract


Background: β-hCG is a marker useful in diagnosis of gestational trophoblastic disease (GTD), ectopic gestation (EG), spontaneous abortion (SA) and malignant germ cell tumors (MGCT) and it is helpful to clinician as an excellent tumor marker. It is useful to monitor treatment whether tumor is responding to treatment or the disease is progressing.

Methods: β-hCG is a marker useful in diagnosis of gestational trophoblastic disease (GTD), ectopic gestation (EG), spontaneous abortion (SA) and malignant germ cell tumors (MGCT) and it is helpful to clinician as an excellent tumor marker. It is useful to monitor treatment whether tumor is responding to treatment or the disease is progressing.

Results: p value is highly significant in Gestational Trophoblastic Diseases, EG and SA, as p value is < 0.005 in all these three categories. But in case of MGCT it is 0.452 which is not significant because study group was very small and one case who developed recurrence affected the value significantly. These findings suggest that β-hCG has definitive prognostic role (p value<0.005) in GTD, EG and SA.

Conclusions: ELISA is rapid, sensitive, reliable and cost effective test for measurement of β-hCG. Pre-and post-therapeutic β-hCG serum levels seem to be useful in the therapy monitoring of trophoblastic gynaecological conditions i.e. GTD, EG and SA.


Keywords


ELISA, Gestational trophoblastic diseases, Neoplasia, Spontaneous abortion

Full Text:

PDF

References


Robins SL, Kumar V, Cotran R S. Robbins basic Pathology. 9th ed Philadelphia: Saunders.2015:1040-41.

McPherson, Pincus RA, Henry MR, Bernard J. Henry’s clinical diagnosis and management by Laboratory Methods. 22nd ed. 1394.

Singh YA, Singh LS, Singh LR, Liyak P, Vaz A. A Study of Molar Pregnancy at Tertiary Centre of India. IOSR JDMS. 1(15):49-52.

Lindstedt G, Lundberg PA, Janson PO, Thorburn J. Biochemical diagnosis of ectopic pregnancy. Scand J Clin Lab Invest. 1982;42(3):201-10.

Sharma JB, Gulati N. Clinicopathological Features of Ovarian Tumours:A Prospective Observational study, Gynecological disorders in geriatric age group. J Obstet Gynecol India. 1990;40:459-63.

Trommel NE, Sweep FCGJ, Schijf CPT, Massugerand LFG, Thomas CMG. Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG a- and b-subunits, and their ratios. Euro J Endocrinol. 2005;153:565-75.

Lenhard M, Tsvilina A, Schumacher L, Kupka M, Ditsch N, Mayr D et al. Human chorionic gonadotropin and its relation to grade, stage and patient survival in ovarian cancer. BMC cancer. 2012;12(1):2.

Shrivastava S, Kataki AC, Barmon D, Deka P, Bhuyan C, Bhargav SJ. Gestational trophoblastic neoplasia: A 6year retrospective study. SAJC. 2014 ;3(1):33.

Berkowitz R, Ozturk M, Goldstein D, Bernstein M, Hill L, Wands JR. Human chorionic gonadotropin and free subunits' serum levels in patients with partial and complete hydatidiform moles. Obstet Gynecol. 1989;74(2):212-6.

Pandey D, Kumar P, Chaturvedi G. Maniarasi. Human Chorionic Gonadotropin: “The Magic Molecule”. IJEN. 2008;5(1).

Babu GS, Supriya NA, Kumar NGR, Swetha P. Tumor markers. J Orofacial Sci. 2012;4(2):87-95.

Perkins GL, Slater ED, Sanders GK, Prichard JG. Serum tumor markers. Am Fam physician. 2003;68(6):1075-88.

World Health Organization. Gestational Trophoblastic Diseases: Report of a WHO Scientific Group. World Health Organization; 1983.

Gurusamy V, Kanchana PM, Srinivasan LN. A 3-year retrospective study on gestational trophoblastic disease in a government obstetrical tertiary care centre. Int J Reprod Contracept Obstet Gynecol. 2016 Dec;5(12):4405-9.

Marella S. Prognostic and predictive markers in early detection of different types of cancers for selected organ sites. IOSR J. Pharm. Biol. Sci. 2013;8:5-42.

Hoskins JW, Perez CA, Young RC, Barakat R, Markman M, Randall M. Human Chorionic Gonadotrophins: Principles and Practice of Gynecologic Oncology. 4th ed.162.